#BEGIN_DRUGCARD DB03522

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C6H9NO6

# Chemical_IUPAC_Name:
(2S)-2-amino-4-(carboxymethoxy)-4-oxobutanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Aspartic Acid-4-Carboxymethyl Ester

# HET_ID:
ASB

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H9NO6/c7-3(6(11)12)1-5(10)13-2-4(8)9/h3H,1-2,7H2,(H,8,9)(H,11,12)/t3-/m0/s1

# InChI_Key:
InChIKey=VYJCBTPDYBSANG-VKHMYHEASA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3522

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
191.1388

# Molecular_Weight_Mono:
191.042987025

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1QQ6

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-3.4

# Predicted_LogS:
-0.96

# Predicted_Water_Solubility:
2.09e+01 g/l

# Primary_Accession_No:
DB03522

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
17753844

# PubChem_Substance_ID:
46505968

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00567

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CC(=O)OCC(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:20 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M81691

# Drug_Target_1_GenBank_ID_Protein:
155350

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
dhlB

# Drug_Target_1_Gene_Sequence:
>762 bp
ATGATCAAGGCAGTCGTGTTCGACGCTTACGGTACGCTCTTCGACGTCCAGTCGGTGGCC
GACGCCACCGAGCGGGCGTATCCAGGCCGGGGCGAGTACATCACGCAGGTCTGGCGGCAG
AAGCAGCTGGAATACAGCTGGCTCCGCGCGCTGATGGGGCGCTATGCCGACTTTTGGGGC
GTCACGCGGGAAGCGCTGGCCTATACCCTCGGAACGCTGGGGCTGGAGCCGGACGAGTCC
TTCCTCGCCGGGATGGCGCAGGCCTACAACCGCCTCACGCCCTATCCGGACGCCGCGCAA
TGCCTCGCGGAGCTGGCGCCCCTCAAGCGCGCCATCCTCTCCAACGGCGCGCCCGACATG
CTGCAGGCGCTCGTGGCCAATGCGGGCCTGACGGACAGCTTCGATGCCGTCATCAGCGTC
GATGCCAAGCGCGTGTTCAAGCCTCATCCCGACTCCTACGCGCTGGTGGAGGAGGTACTA
GGCGTGACGCCCGCGGAGGTGCTGTTCGTGTCCTCCAACGGCTTCGACGTCGGCGGCGCG
AAGAATTTCGGCTTCAGCGTCGCCCGGGTCGCGCGCCTGTCGCAGGAGGCGCTGGCGCGC
GAACTCGTCTCGGGTACCATCGCGCCCCTGACCATGTTCAAGGCGCTGAGGATGCGGGAA
GAAACCTATGCGGAGGCGCCTGATTTCGTGGTGCCCGCCCTTGGCGACCTGCCGCGGCTG
GTTCGCGGGATGGCCGGCGCTCATCTCGCACCAGCGGTGTGA

# Drug_Target_1_General_Function:
Involved in haloacid dehalogenase activity

# Drug_Target_1_General_References:
1744048	van der Ploeg J, van Hall G, Janssen DB: Characterization of the haloacid dehalogenase from Xanthobacter autotrophicus GJ10 and sequencing of the dhlB gene. J Bacteriol. 1991 Dec;173(24):7925-33.
7580000	van der Ploeg J, Janssen DB: Sequence analysis of the upstream region of dhlB, the gene encoding haloalkanoic acid dehalogenase of Xanthobacter autotrophicus GJ10. Biodegradation. 1995 Sep;6(3):257-63.
9407083	Ridder IS, Rozeboom HJ, Kalk KH, Janssen DB, Dijkstra BW: Three-dimensional structure of L-2-haloacid dehalogenase from Xanthobacter autotrophicus GJ10 complexed with the substrate-analogue formate. J Biol Chem. 1997 Dec 26;272(52):33015-22.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2929

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
27470

# Drug_Target_1_Name:
(S)-2-haloacid dehalogenase

# Drug_Target_1_Number_of_Residues:
253

# Drug_Target_1_PDB_ID:
1AQ6

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00702	Hydrolase

# Drug_Target_1_Protein_Sequence:
>(S)-2-haloacid dehalogenase
MIKAVVFDAYGTLFDVQSVADATERAYPGRGEYITQVWRQKQLEYSWLRALMGRYADFWG
VTREALAYTLGTLGLEPDESFLADMAQAYNRLTPYPDAAQCLAELAPLKRAILSNGAPDM
LQALVANAGLTDSFDAVISVDAKRVFKPHPDSYALVEEVLGVTPAEVLFVSSNGFDVGGA
KNFGFSVARVARLSQEALARELVSGTIAPLTMFKALRMREETYAEAPDFVVPALGDLPRL
VRGMAGAHLAPAV

# Drug_Target_1_Reaction:
(S)-2-haloacid + H2O = (R)-2-hydroxyacid + halide

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the hydrolytic dehalogenation of small L-2- haloalkanoic acids to yield the corresponding D-2-hydroxyalkanoic acids. Active with 2-halogenated carboxylic acids and converts only the L-isomer of 2-chloropropionic acid with inversion of configuration to produce D-lactate

# Drug_Target_1_SwissProt_ID:
Q60099

# Drug_Target_1_SwissProt_Name:
HAD_XANAU

# Drug_Target_1_Synonyms:
2-haloalkanoic acid dehalogenase
EC 3.8.1.2
Halocarboxylic acid halidohydrolase
L-2-haloacid dehalogenase

# Drug_Target_1_Theoretical_pI:
4.71

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03522
